Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Current paradigm and futuristic vision on new-onset diabetes and pancreatic cancer research

23 May 2025

Abstract excerpt

New-onset diabetes (NOD) has emerged as a potential early indicator of pancreatic cancer (PC), necessitating a refined clinical approach for risk assessment and early detection. This study discusses critical gaps in understanding the NOD-PC relationship and proposes a multifaceted approach to enhance early detection and risk assessment. We present a comprehensive clinical workflow for evaluating NOD patients,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Genomics and Diagnostics
Share to Metabolism, Diabetes, and Cancer
Share to Pancreatic and Hepatic Oncology Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 40487412
DOI: 10.3389/fphar.2025.1543112

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Current paradigm and futuristic vision on new-onset diabetes and pancreatic cancer researchPMID 40487412Read ↗

Predicting Pancreatic Cancer in New-Onset Diabetes Cohort Using a Novel Model With Integrated Clinical and Genetic Indicators: A Large-Scale Prospective Cohort Study.Semantic proximity Read ↗

External UK validation of the ENDPAC model to predict pancreatic cancer risk: A registered report protocolSemantic proximity Read ↗

From classical approaches to artificial intelligence, old and new tools for PDAC risk stratification and prediction.Semantic proximity Read ↗

From omics to AI —mapping the pathogenic pathways in type 2 diabetesSemantic proximity Read ↗

Enhancing Early Detection of Pancreatic Cancer in Genetically Predisposed Individuals: Integrating Advanced Imaging Modalities with Emerging Biomarkers and Liquid BiopsySemantic proximity Read ↗

Next-generation epidemiology: the role of high-resolution molecular phenotyping in diabetes research.Semantic proximity Read ↗

Insights into the molecular underpinning of type 2 diabetes complicationsSemantic proximity Read ↗

Large-scale multi-omics enhance risk prediction for type 2 diabetes.Semantic proximity Read ↗

Diabetes, Pancreatogenic Diabetes, and Pancreatic Cancer.Semantic proximity Read ↗

New-onset Diabetes Mellitus After Different Surgical Procedures for Pancreatic Malignant Tumors: A Comparative Study and Construction of a Diabetes Prediction ModelSemantic proximity Read ↗

Discovering a trans-omics biomarker signature that predisposes high risk diabetic patients to diabetic kidney diseaseSemantic proximity Read ↗

Identification of patients at risk for pancreatic cancer in a 3-year timeframe based on machine learning algorithmsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.